Biofrontera AG, Biofrontera Pharma GmbH and Biofrontera Bioscience GmbH Deal History & Licensing Activity
Biofrontera AG, Biofrontera Pharma GmbH and Biofrontera Bioscience GmbH is a life sciences. Over the past three years, Biofrontera AG, Biofrontera Pharma GmbH and Biofrontera Bioscience GmbH has been involved in 1 licensing and acquisition transaction, with a primary focus on Other (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Other
Focus Area
Dermatology
Biofrontera AG, Biofrontera Pharma GmbH and Biofrontera Bioscience GmbH Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Biofrontera AG, Biofrontera Pharma GmbH and Biofrontera Bioscience GmbH in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Ameluz | Biofrontera Inc. | Other | Approved | acquisition | Jul 2025 |
Biofrontera AG, Biofrontera Pharma GmbH and Biofrontera Bioscience GmbH Pipeline Focus
Therapeutic areas and modalities where Biofrontera AG, Biofrontera Pharma GmbH and Biofrontera Bioscience GmbH is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches Biofrontera AG, Biofrontera Pharma GmbH and Biofrontera Bioscience GmbH's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Dermatology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Dermatology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for dermatology
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Biofrontera AG, Biofrontera Pharma GmbH and Biofrontera Bioscience GmbH Licensing & Deal Activity
Biofrontera AG, Biofrontera Pharma GmbH and Biofrontera Bioscience GmbH is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Biofrontera AG, Biofrontera Pharma GmbH and Biofrontera Bioscience GmbH ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Biofrontera AG, Biofrontera Pharma GmbH and Biofrontera Bioscience GmbH include Dermatology (2 deals and trials). In terms of modality, Biofrontera AG, Biofrontera Pharma GmbH and Biofrontera Bioscience GmbH has shown particular interest in other.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Biofrontera AG, Biofrontera Pharma GmbH and Biofrontera Bioscience GmbH and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Biofrontera AG, Biofrontera Pharma GmbH and Biofrontera Bioscience GmbH's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.